Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Zhai

Showing results (141-150 of 145) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 145 results.
Zhonghua Yi Xue Za Zhi|July 30, 2024
[Interim efficacy of a multicenter cohort study for China Net Childhood Lymphoma mature B-cell lymphoma 2017 regimen in the treatment of pediatric High-grade-B cell lymphoma]Y Zhao, S Huang, Y P Jia, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|September 27, 2024
[A multicenter study on effect of delayed chemotherapy on prognosis of Burkitt lymphoma in children]L Song, L Jin, Y H Zhang, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|October 8, 2022
[Mid-term efficacy of China Net Childhood Lymphoma-mature B-cell lymphoma 2017 regimen in the treatment of pediatric Burkitt lymphoma]M Zhang, P Wu, Y L Duan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2023
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III studyX Q Yan, M J Ye, Q Zou, et al.
Cellr4-- Repair, Replacement, Regeneration, & Reprogramming|January 8, 2019
Purified Human Pancreatic Islets, CIT Culture Media with Lisofylline or Exenatide, J Ansite, A N Balamurugan, et al.
Pageof 15

Showing results (141-150 of 145) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 145 results.
Zhonghua Yi Xue Za Zhi|July 30, 2024
[Interim efficacy of a multicenter cohort study for China Net Childhood Lymphoma mature B-cell lymphoma 2017 regimen in the treatment of pediatric High-grade-B cell lymphoma]Y Zhao, S Huang, Y P Jia, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|September 27, 2024
[A multicenter study on effect of delayed chemotherapy on prognosis of Burkitt lymphoma in children]L Song, L Jin, Y H Zhang, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|October 8, 2022
[Mid-term efficacy of China Net Childhood Lymphoma-mature B-cell lymphoma 2017 regimen in the treatment of pediatric Burkitt lymphoma]M Zhang, P Wu, Y L Duan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2023
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III studyX Q Yan, M J Ye, Q Zou, et al.
Cellr4-- Repair, Replacement, Regeneration, & Reprogramming|January 8, 2019
Purified Human Pancreatic Islets, CIT Culture Media with Lisofylline or Exenatide, J Ansite, A N Balamurugan, et al.
Pageof 15